These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 7704956)

  • 1. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
    Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of dissociation of cortisol and adrenal androgen secretion after removal of adrenocortical adenoma in patients with Cushing's syndrome.
    Nawata H; Higuchi K; Yanase T; Takayanagi R; Kato K; Ibayashi H
    Endocrinol Jpn; 1985 Oct; 32(5):691-700. PubMed ID: 2936600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical Cushing's syndrome in adrenal incidentaloma.
    Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
    Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
    Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
    Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
    Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.
    Tsagarakis S; Tsigos C; Vassiliou V; Tsiotra P; Pratsinis H; Kletsas D; Trivizas P; Nikou A; Mavromatis T; Sotsiou F; Raptis S; Thalassinos N
    J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
    Mantero F; Masini AM; Opocher G; Giovagnetti M; Arnaldi G
    Horm Res; 1997; 47(4-6):284-9. PubMed ID: 9167966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone.
    Hensen J; Buhl M; Bähr V; Oelkers W
    Klin Wochenschr; 1990 Jun; 68(12):608-14. PubMed ID: 2165544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal incidentalomas showing unilateral concordant visualization by adrenocortical scintigraphy: comparison with adenomas in Cushing's syndrome.
    Tani A; Nakajo M; Tsuchimochi S; Nakabeppu Y; Umanodan T
    Ann Nucl Med; 2000 Jun; 14(3):205-12. PubMed ID: 10921486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation.
    Grossrubatscher E; Vignati F; Possa M; Lohi P
    J Endocrinol Invest; 2001 Dec; 24(11):846-55. PubMed ID: 11817708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
    Dennedy MC; Annamalai AK; Prankerd-Smith O; Freeman N; Vengopal K; Graggaber J; Koulouri O; Powlson AS; Shaw A; Halsall DJ; Gurnell M
    J Clin Endocrinol Metab; 2017 Mar; 102(3):786-792. PubMed ID: 27797672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients.
    Kasperlik-Zeluska AA; Rosłonowska E; Słowinska-Srzednicka J; Migdalska B; Jeske W; Makowska A; Snochowska H
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):29-37. PubMed ID: 9059555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pre-toxic adrenocortical adenoma ("pre-Cushing syndrome"): role of 17-hydroxyprogesterone dosage under ACTH analog stimulation. Apropos of a case].
    Vlaeminck V; Dewailly D
    Ann Endocrinol (Paris); 1997; 58(5):413-7; discussion 417-20. PubMed ID: 9686000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cortisol secretion in hormonally inactive adrenocortical incidentalomas: study of in vitro steroid secretion and immunohistochemical localization of steroidogenic enzymes.
    Midorikawa S; Sanada H; Hashimoto S; Suzuki T; Watanabe T; Sasano H
    Endocr J; 2001 Apr; 48(2):167-74. PubMed ID: 11456263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma.
    Levine AC; Mitty HA; Gabrilove JL
    J Urol; 1988 Jul; 140(1):11-5. PubMed ID: 2967899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas.
    Klose M; Jørgensen K; Kristensen LØ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):394-9. PubMed ID: 15355458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
    Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.